Clinical Trial Update: Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on neoadjuvant chemotherapy for epithelial ovarian cancer with related fallopian tube and peritoneal carcinomas; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Carcinoma
• Ovarian Cancer
• Peritoneal Carcinoma

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Ovarian Cancer, Fallopian Tube Carcinoma | Phase 2 | Status: UNKNOWN